| CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo SE Perea, O Reyes, I Baladron, Y Perera, H Farina, J Gil, A Rodriguez, ... Molecular and cellular biochemistry 316, 163-167, 2008 | 125 | 2008 |
| Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies AM Solares, A Santana, I Baladrón, C Valenzuela, CA González, A Díaz, ... BMC cancer 9, 1-9, 2009 | 91 | 2009 |
| Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study MT Milanes-Virelles, I Garcia-Garcia, Y Santos-Herrera, ... BMC infectious diseases 8, 1-13, 2008 | 79 | 2008 |
| Variable Level Expression of Hepatitis C Virus Core Protein in a Prokaryotic System. Analysis of the Humoral Response against It in Rabbits S Dueñas-Carrera, J Morales, N Acosta-Rivero, LJ Lorenzo, C García, ... Biotecnología Aplicada 16, 226-231, 1999 | 25 | 1999 |
| The Hitchhiker’s guide to human therapeutic nanoparticle development TI Ramos, CA Villacis-Aguirre, KV López-Aguilar, L Santiago Padilla, ... Pharmaceutics 14 (2), 247, 2022 | 15 | 2022 |
| Forms and methods for interferon´s encapsulation. TI Ramos, CA Villacis-Aguirre, NS Vispo, LS Padilla, SP Santana, ... Pharmaceutic 13 (10), 1533, 2021 | 11 | 2021 |
| Contexto actual de los estudios preclínicos TI Ramos Bionatura 1 (3), 103-105, 2016 | 5 | 2016 |
| From the laboratory to the industry: enzymatic production and applications of short chain fructooligosaccharides (fos). Recent advances and current perspectives TR . LE. Trujillo, VE. Marcillo, R. Avalos, LK. Ponce Revista Bionatura. 1 (1), 112-117, 2015 | 4* | 2015 |
| Recombinant gamma interferon for the treatment of pulmonary and mycobacterial diseases I García, MT Milanés, I Cayón, Y Santos, C Valenzuela, P López, ... Biotecnologia Aplicada 26, 157-61, 2009 | 4 | 2009 |
| Establishment of a production process for a novel vaccine candidate against Lawsonia intracellularis RM S.Salazar, N.Gutiérrez, O.Sánchez, E.Ramos, A.González, J.Acosta, T.Ramos ... Electronic Journal of Biotechnology 50, 45-52, 2021 | 1 | 2021 |
| FSH in bovine superovulation VMB Vega, SPJ Chávez, CDM Franco, TI Ramos, JR Toledo | 1 | |
| Obtención de una novedosa formulación que permita la nanoencapsulación de interferón alfa 2b recombinante humano (rhIFNα-2b) CA Villacís Aguirre | | 2021 |
| Reporte de caso de postcirugía de ligamento cruzado anterior TIR Clara Gualotuña Bionatura 8 (15), 2021 | | 2021 |
| Establecimiento de un proceso productivo a escala de laboratorio para la obtención de antígenos recombinantes contra Lawsonia intracellularis, causante de la enteropatía … SA Salazar Guamán | | 2020 |
| Investigación Clínica & Ensayos Clínicos Desafíos y Pers-pectivas TI Ramos Bionatura, 423, 2017 | | 2017 |
| A Direct and Sensitive Method for Screening Fructooligosaccharides-Digesting Microorganisms Useful In Food and Health Science. Trujillo LE Trujillo, S * Granda, MI Ordoñez, TI Ramos, R Avalos African Journal of Biotechnology 14 (38), 2759-2764, 2015 | | 2015 |
| A genetically modified Pichia pastoris based biocatalist for short chain FOS production from sucrose TR LE. Trujillo, VE. Marcillo, R. Avalos, LK. Ponce Journal Fermentation Tecnology 3 (2), 2015 | | 2015 |
| A genetically modified Pichia pastoris based biocatalist for short chain FOS production from sucrose. LE Trujillo, VE Marcillo, R Avalos, LK Ponce, T Ramos Journal Fermentation Tecnology 3 (2), 2015 | | 2015 |
| New projections of Clinical Research in Ecuador TIR Gómez Revista Bionatura. 2 (2), 2015 | | 2015 |
| Application of CIG-228 with adjuvant VSSP in high grade cervical lesion. TMI Ramos-Gómez TI, Baladrón Castillo I, Ale Martínez M, Nazabal Gálvez M ... Vaccimonitor 19 (S-2.), 293, 2010 | | 2010 |
Idrian García GarcíaUniversidad de Ciencias Médicas de La Habana, Facultad de Ciencias Médicas Miguel EnríquezVerified email at infomed.sld.cu
